1. | tullyenterprises | |
2. | kimhen4 | |
3. | clarkbar7 | |
4. | carter0 |
1. | tullyenterprises | |
2. | kimhen4 | |
3. | clarkbar7 | |
4. | carter0 |
1. | kimhen4 01/09/2018 News to come. |
2. | tullyenterprises 03/22/2018 Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain |